Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza.

Hossain MJ, Bourgeois M, Quan FS, Lipatov AS, Song JM, Chen LM, Compans RW, York I, Kang SM, Donis RO.

Clin Vaccine Immunol. 2011 Dec;18(12):2010-7. doi: 10.1128/CVI.05206-11. Epub 2011 Oct 26.

PMID:
22030367
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Influenza virus vaccines: lessons from the 2009 H1N1 pandemic.

Broadbent AJ, Subbarao K.

Curr Opin Virol. 2011 Oct;1(4):254-62. doi: 10.1016/j.coviro.2011.08.002. Review.

PMID:
22125588
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Influenza vaccines based on virus-like particles.

Kang SM, Song JM, Quan FS, Compans RW.

Virus Res. 2009 Aug;143(2):140-6. doi: 10.1016/j.virusres.2009.04.005. Epub 2009 Apr 15. Review.

PMID:
19374929
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic.

López-Macías C.

Hum Vaccin Immunother. 2012 Mar;8(3):411-4. doi: 10.4161/hv.18757. Epub 2012 Feb 14. Review.

PMID:
22330956
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Virus-like particles as universal influenza vaccines.

Kang SM, Kim MC, Compans RW.

Expert Rev Vaccines. 2012 Aug;11(8):995-1007. Review.

PMID:
23002980
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Novel vaccines against influenza viruses.

Kang SM, Song JM, Compans RW.

Virus Res. 2011 Dec;162(1-2):31-8. doi: 10.1016/j.virusres.2011.09.037. Epub 2011 Oct 1. Review.

PMID:
21968298
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Influenza virus hemagglutinin stalk-based antibodies and vaccines.

Krammer F, Palese P.

Curr Opin Virol. 2013 Oct;3(5):521-30. doi: 10.1016/j.coviro.2013.07.007. Epub 2013 Aug 24. Review.

PMID:
23978327
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Traditional and new influenza vaccines.

Wong SS, Webby RJ.

Clin Microbiol Rev. 2013 Jul;26(3):476-92. doi: 10.1128/CMR.00097-12. Review.

PMID:
23824369
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

[Study of next generation influenza vaccine focused on "cross-protection by mucosal immunization" and "seed virus strains"].

Okamoto S.

Yakugaku Zasshi. 2013;133(3):313-21. Review. Japanese.

PMID:
23449407
[PubMed - indexed for MEDLINE]
Free Article
10.

Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing.

Oxford JS.

Br J Clin Pharmacol. 2013 Aug;76(2):210-6. doi: 10.1111/bcp.12146. Review.

PMID:
23617282
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

[Virus-like particles--a new strategy for production of vaccines against influenza virus].

Petukhova NV, Ivanov PA, Migunov AI.

Vopr Virusol. 2013 Mar-Apr;58(2):10-4. Review. Russian.

PMID:
23785764
[PubMed - indexed for MEDLINE]
12.

[Progress in development of influenza virus-like particles].

Ge SQ, Wang ZL.

Bing Du Xue Bao. 2013 Mar;29(2):224-32. Review. Chinese.

PMID:
23757857
[PubMed - indexed for MEDLINE]
13.

Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use.

Lee DH, Park JK, Song CS.

Clin Exp Vaccine Res. 2014 Jul;3(2):133-9. doi: 10.7774/cevr.2014.3.2.133. Epub 2014 Jun 20. Review.

PMID:
25003086
[PubMed]
Free PMC Article
14.

Virus-like particles: promising platforms with characteristics of DIVA for veterinary vaccine design.

Liu F, Wu X, Li L, Ge S, Liu Z, Wang Z.

Comp Immunol Microbiol Infect Dis. 2013 Jul;36(4):343-52. doi: 10.1016/j.cimid.2013.02.002. Epub 2013 Apr 3. Review.

PMID:
23561290
[PubMed - indexed for MEDLINE]
15.

Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches.

Thompson CM, Petiot E, Lennaertz A, Henry O, Kamen AA.

Virol J. 2013 May 4;10:141. doi: 10.1186/1743-422X-10-141. Review.

PMID:
23642219
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Animal models to assess the toxicity, immunogenicity and effectiveness of candidate influenza vaccines.

Eichelberger MC, Green MD.

Expert Opin Drug Metab Toxicol. 2011 Sep;7(9):1117-27. doi: 10.1517/17425255.2011.602065. Epub 2011 Jul 12. Review.

PMID:
21749266
[PubMed - indexed for MEDLINE]
17.

Animal models for influenza viruses: implications for universal vaccine development.

Margine I, Krammer F.

Pathogens. 2014 Oct 21;3(4):845-74. doi: 10.3390/pathogens3040845. Review.

PMID:
25436508
[PubMed]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk